文献速递基础与转化研究组学、生物样本库与精准医学

阿尔茨海默病前瞻性纵向萎缩与基线tau-PET的强度和分布相关

Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET.
PubMed 文献 · Sci Transl Med · 2020-01-01

研究纳入32例早期症状性阿尔茨海默病患者,在PET检查时及15个月后分别进行纵向磁共振成像,检验β-淀粉样蛋白和tau-PET能否预测后续脑萎缩。定量分析显示,tau-PET全局信号强度而非β-淀粉样蛋白-PET可预测后续萎缩速率,且tau-PET信号分布可指示未来萎缩的拓扑位置。

要点

  • tau-PET全局信号强度可预测早期症状性AD患者后续脑萎缩速率。
  • β-淀粉样蛋白-PET信号未显示预测后续萎缩速率的能力。
  • tau-PET信号分布可提示未来萎缩的拓扑位置。

核心结论

  • tau病理是局部神经退行性变的主要驱动因素,tau-PET可作为精准医学工具预测个体患者进展并设计未来临床试验。

研究设计与样本

  • 研究纳入32例早期症状性阿尔茨海默病患者,在PET检查时及15个月后分别进行纵向磁共振成像以测量后续脑萎缩。

主要发现

  • tau-PET全局信号强度而非β-淀粉样蛋白-PET信号可预测后续萎缩速率,且独立于基线皮质厚度。
  • tau-PET信号的特定分布是单患者层面未来萎缩拓扑位置的强指示指标。
  • 基线tau-PET与后续萎缩的关系在较年轻患者中尤其强。

临床怎么用

  • tau-PET可用于预测早期症状性AD患者的个体化进展并辅助未来临床试验设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

β-Amyloid plaques and tau-containing neurofibrillary tangles are the two neuropathological hallmarks of Alzheimer's disease (AD) and are thought to play crucial roles in a neurodegenerative cascade leading to dementia. Both lesions can now be visualized in vivo using positron emission tomography (PET) radiotracers, opening new opportunities to study disease mechanisms and improve patients' diagnostic and prognostic evaluation. In a group of 32 patients at early symptomatic AD stages, we tested whether β-amyloid and tau-PET could predict subsequent brain atrophy measured using longitudinal magnetic resonance imaging acquired at the time of PET and 15 months later. Quantitative analyses showed that the global intensity of tau-PET, but not β-amyloid-PET, signal predicted the rate of subsequent atrophy, independent of baseline cortical thickness. Additional investigations demonstrated that the specific distribution of tau-PET signal was a strong indicator of the topography of future atrophy at the single patient level and that the relationship between baseline tau-PET and subsequent atrophy was particularly strong in younger patients. These data support disease models in which tau pathology is a major driver of local neurodegeneration and highlight the relevance of tau-PET as a precision medicine tool to help predict individual patient's progression and design future clinical trials.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. La Joie R, Visani AV, Baker SL, et al. Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020. PMID: 31894103. doi:10.1126/scitranslmed.aau5732

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。